Stoke Therapeutics
STOK
$13.90
Share price
-0.93%
Change (1 day)
23.34%
Change (1 year)
Categories
Stoke Therapeutics (STOK) - Cash on Hand
Cash on Hand as of December 2023 : $0.20 B
According to Stoke Therapeutics's latest financial reports the company has $0.20 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Stoke Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.22 B | 4.45% |
| 2021-12-31 | $0.21 B | -23.49% |
| 2020-12-31 | $0.28 B | 29.14% |
| 2019-12-31 | $0.22 B | 111.08% |
| 2018-12-31 | $0.10 B | 5765.28% |
| 2017-12-31 | $1.79 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 3.37% | 🇺🇸 USA |